Throughout the last three months, 16 analysts have evaluated Colgate-Palmolive CL, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 6 | 4 | 5 | 1 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 1 | 0 |
2M Ago | 1 | 0 | 1 | 0 | 0 |
3M Ago | 5 | 2 | 4 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Colgate-Palmolive, presenting an average target of $106.81, a high estimate of $122.00, and a low estimate of $91.00. This upward trend is apparent, with the current average reflecting a 4.56% increase from the previous average price target of $102.15.
Investigating Analyst Ratings: An Elaborate Study
In examining recent analyst actions, we gain insights into how financial experts perceive Colgate-Palmolive. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Andrea Teixeira | JP Morgan | Raises | Overweight | $114.00 | $113.00 |
Korinne Wolfmeyer | Piper Sandler | Announces | Overweight | $121.00 | - |
Chris Carey | Wells Fargo | Announces | Underweight | $100.00 | - |
Steve Powers | Deutsche Bank | Raises | Hold | $109.00 | $107.00 |
Peter Grom | UBS | Raises | Buy | $122.00 | $119.00 |
Robert Moskow | TD Cowen | Raises | Buy | $115.00 | $110.00 |
Callum Elliott | Bernstein | Raises | Market Perform | $103.00 | $100.00 |
Steve Powers | Deutsche Bank | Raises | Buy | $107.00 | $104.00 |
Dara Mohsenian | Morgan Stanley | Raises | Overweight | $111.00 | $103.00 |
Lauren Lieberman | Barclays | Raises | Equal-Weight | $96.00 | $91.00 |
Kaumil Gajrawala | Jefferies | Lowers | Hold | $95.00 | $103.00 |
Robert Moskow | TD Cowen | Announces | Buy | $110.00 | - |
Mark Astrachan | Stifel | Raises | Buy | $105.00 | $95.00 |
Lauren Lieberman | Barclays | Raises | Equal-Weight | $91.00 | $85.00 |
Robert Ottenstein | Evercore ISI Group | Raises | Outperform | $106.00 | $100.00 |
Steve Powers | Deutsche Bank | Raises | Buy | $104.00 | $98.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Colgate-Palmolive. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Colgate-Palmolive compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Colgate-Palmolive's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
For valuable insights into Colgate-Palmolive's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Colgate-Palmolive analyst ratings.
Delving into Colgate-Palmolive's Background
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
Colgate-Palmolive's Economic Impact: An Analysis
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Colgate-Palmolive's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 4.89%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: Colgate-Palmolive's net margin is impressive, surpassing industry averages. With a net margin of 14.45%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 414.16%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Colgate-Palmolive's ROA stands out, surpassing industry averages. With an impressive ROA of 4.42%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Colgate-Palmolive's debt-to-equity ratio stands notably higher than the industry average, reaching 70.54. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Analyst Ratings: Simplified
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.